Vault-13

Deep Track Capital, LP

GREENWICH, CT · CIK 1856083 · 13F filing filed 2023-09-06

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$2.1bn reported value -9.0% vs Q1 2023
53positions
51.6%in top 10
12 new 13 added 13 reduced 13 sold out vs Q1 2023

Options: 1 call positions ($2.1m notional), 1 put positions ($17.1m notional) – listed below, not included above.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 1,250,000 $155.0m7.24% 7.24% AddedShares held: Q3 2022 861.0k, Q4 2022 873.6k, Q1 2023 1.2m, Q2 2023 1.2m +50.0k +50,000 4.2%
2 INSMED INC COM PAR $.01 INSM INSM 6,500,000 $137.2m6.41% 6.41% UnchangedShares held: Q3 2022 0, Q4 2022 4.3m, Q1 2023 6.5m, Q2 2023 6.5m
3 IONIS PHARMACEUTICALS INC COM IONS IONS 2,834,069 $116.3m5.43% 5.43% UnchangedShares held: Q3 2022 0, Q4 2022 1.2m, Q1 2023 2.8m, Q2 2023 2.8m
4 TRAVERE THERAPEUTICS INC COM TVTX TVTX 7,370,000 $113.2m5.29% 5.29% AddedShares held: Q3 2022 4.0m, Q4 2022 4.6m, Q1 2023 6.1m, Q2 2023 7.4m +1.2m +1,222,732 19.9%
5 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 2,646,782 $110.0m5.14% 5.14% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.6m, Q2 2023 2.6m
6 IMMUNOVANT INC COM IMVT IMVT 5,421,330 $102.8m4.80% 4.80% ReducedShares held: Q3 2022 9.9m, Q4 2022 9.7m, Q1 2023 7.4m, Q2 2023 5.4m -2.0m -2,011,387 -27.1%
7 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 1,548,252 $98.0m4.58% 4.58% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.7m, Q2 2023 1.5m -151.7k -151,748 -8.9%
8 ALKERMES PLC SHS ALKS ALKS 3,000,000 $93.9m4.39% 4.39% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.0m, Q2 2023 3.0m
9 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 3,546,435 $93.0m4.34% 4.34% AddedShares held: Q3 2022 2.4m, Q4 2022 3.1m, Q1 2023 3.1m, Q2 2023 3.5m +446.4k +446,435 14.4%
10 DYNAVAX TECHNOLOGIES CORP COM NEW DVAX DVAX 6,557,816 $84.7m3.96% 3.96% AddedShares held: Q3 2022 0, Q4 2022 2.3m, Q1 2023 6.3m, Q2 2023 6.6m +207.8k +207,816 3.3%
11 GERON CORP COM GERN GERN 24,170,966 $77.6m3.62% 3.62% ReducedShares held: Q3 2022 0, Q4 2022 7.4m, Q1 2023 26.9m, Q2 2023 24.2m -2.7m -2,696,513 -10.0%
12 PLIANT THERAPEUTICS INC COM PLRX PLRX 4,050,000 $73.4m3.43% 3.43% AddedShares held: Q3 2022 1.4m, Q4 2022 1.7m, Q1 2023 3.4m, Q2 2023 4.0m +627.9k +627,943 18.4%
13 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 2,819,045 $71.9m3.36% 3.36% UnchangedShares held: Q3 2022 2.9m, Q4 2022 2.8m, Q1 2023 2.8m, Q2 2023 2.8m
14 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 3,187,415 $67.4m3.15% 3.15% UnchangedShares held: Q3 2022 2.8m, Q4 2022 3.2m, Q1 2023 3.2m, Q2 2023 3.2m
15 GUARDANT HEALTH INC COM GH GH 1,500,000 $53.7m2.51% 2.51% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.5m
16 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 2,778,107 $50.2m2.34% 2.34% AddedShares held: Q3 2022 3.2m, Q4 2022 2.7m, Q1 2023 2.3m, Q2 2023 2.8m +500.0k +500,000 21.9%
17 AGENUS INC COM NEW COM NEW 30,000,000 $48.0m2.24% 2.24% UnchangedShares held: Q3 2022 26.3m, Q4 2022 27.0m, Q1 2023 30.0m, Q2 2023 30.0m
18 BEAM THERAPEUTICS INC COM BEAM BEAM 1,317,316 $42.1m1.96% 1.96% AddedShares held: Q3 2022 1.0m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.3m +67.3k +67,316 5.4%
19 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 15,000,000 $35.7m1.67% 1.67% UnchangedShares held: Q3 2022 0, Q4 2022 15.0m, Q1 2023 15.0m, Q2 2023 15.0m
20 INTELLIA THERAPEUTICS INC COM NTLA NTLA 835,446 $34.1m1.59% 1.59% AddedShares held: Q3 2022 300.0k, Q4 2022 700.0k, Q1 2023 704.5k, Q2 2023 835.4k +130.9k +130,913 18.6%
21 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,279,502 $30.4m1.42% 1.42% AddedShares held: Q3 2022 2.0m, Q4 2022 1.8m, Q1 2023 1.2m, Q2 2023 1.3m +49.2k +49,243 4.0%
22 NURIX THERAPEUTICS INC COM NRIX NRIX 2,997,830 $29.9m1.40% 1.40% UnchangedShares held: Q3 2022 2.1m, Q4 2022 2.3m, Q1 2023 3.0m, Q2 2023 3.0m
23 REPARE THERAPEUTICS INC COM RPTX RPTX 2,727,606 $28.9m1.35% 1.35% UnchangedShares held: Q3 2022 3.1m, Q4 2022 2.7m, Q1 2023 2.7m, Q2 2023 2.7m
24 EDITAS MEDICINE INC COM EDIT EDIT 3,453,744 $28.4m1.33% 1.33% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 3.5m
25 DYNE THERAPEUTICS INC COM DYN DYN 2,499,912 $28.1m1.31% 1.31% AddedShares held: Q3 2022 3.2m, Q4 2022 2.7m, Q1 2023 2.3m, Q2 2023 2.5m +165.3k +165,279 7.1%
26 ANI PHARMACEUTICALS INC COM ANIP ANIP 514,021 $27.7m1.29% 1.29% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 514.0k
27 AXSOME THERAPEUTICS INC COM AXSM AXSM 384,200 $27.6m1.29% 1.29% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 384.2k
28 POINT BIOPHARMA GLOBAL INC COM COM 2,781,565 $25.2m1.18% 1.18% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.3m, Q2 2023 2.8m +436.5k +436,492 18.6%
29 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 2,750,000 $21.3m1.00% 1.00% ReducedShares held: Q3 2022 3.4m, Q4 2022 3.4m, Q1 2023 3.1m, Q2 2023 2.8m -318.3k -318,259 -10.4%
30 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 2,523,000 $20.7m0.97% 0.97% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.5m
31 PACIFIC BIOSCIENCES CALIF IN COM PACB PACB 1,451,201 $19.3m0.90% 0.90% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.5m, Q2 2023 1.5m -2.1m -2,053,189 -58.6%
32 ACUMEN PHARMACEUTICALS INC COM ABOS ABOS 3,916,361 $18.8m0.88% 0.88% ReducedShares held: Q3 2022 3.8m, Q4 2022 4.0m, Q1 2023 4.0m, Q2 2023 3.9m -35.6k -35,639 -0.9%
33 RAPT THERAPEUTICS INC COM COM 1,004,561 $18.8m0.88% 0.88% AddedShares held: Q3 2022 0, Q4 2022 1.3m, Q1 2023 571.2k, Q2 2023 1.0m +433.3k +433,328 75.9%
34 VIGIL NEUROSCIENCE INC COM VIGL VIGL 1,773,409 $16.7m0.78% 0.78% ReducedShares held: Q3 2022 2.4m, Q4 2022 2.1m, Q1 2023 2.0m, Q2 2023 1.8m -251.7k -251,728 -12.4%
35 ASTRIA THERAPEUTICS INC COM CATB CATB 1,697,415 $14.1m0.66% 0.66% ReducedShares held: Q3 2022 0, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 1.7m -119.1k -119,116 -6.6%
36 NUVATION BIO INC COM CL A NUVB NUVB 7,720,688 $13.9m0.65% 0.65% UnchangedShares held: Q3 2022 9.3m, Q4 2022 8.2m, Q1 2023 7.7m, Q2 2023 7.7m
37 MORPHIC HLDG INC COM MORF MORF 216,752 $12.4m0.58% 0.58% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 216.8k
38 SILENCE THERAPEUTICS PLC ADS SLN SLN 1,951,580 $10.7m0.50% 0.50% UnchangedShares held: Q3 2022 2.0m, Q4 2022 2.0m, Q1 2023 2.0m, Q2 2023 2.0m
39 ORCHARD THERAPEUTICS PLC SPON ADS ORTX ORTX 2,041,670 $10.6m0.50% 0.50% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.0m
40 NEKTAR THERAPEUTICS COM COM 17,973,464 $10.3m0.48% 0.48% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.7m, Q2 2023 18.0m +16.2m +16,230,216 931.0%
41 TERNS PHARMACEUTICALS INC COM COM 1,099,192 $9.6m0.45% 0.45% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.1m
42 89BIO INC COM ETNB ETNB 503,100 $9.5m0.45% 0.45% ReducedShares held: Q3 2022 2.6m, Q4 2022 3.9m, Q1 2023 1.8m, Q2 2023 503.1k -1.3m -1,296,900 -72.0%
43 INOZYME PHARMA INC COM COM 1,644,021 $9.2m0.43% 0.43% ReducedShares held: Q3 2022 3.2m, Q4 2022 3.2m, Q1 2023 3.2m, Q2 2023 1.6m -1.6m -1,605,979 -49.4%
44 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 300,300 $8.5m0.40% 0.40% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 300.3k
45 RELMADA THERAPEUTICS INC COM RLMD RLMD 2,837,818 $7.0m0.33% 0.33% UnchangedShares held: Q3 2022 460.9k, Q4 2022 2.8m, Q1 2023 2.8m, Q2 2023 2.8m
46 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 499,400 $5.9m0.28% 0.28% UnchangedShares held: Q3 2022 499.4k, Q4 2022 499.4k, Q1 2023 499.4k, Q2 2023 499.4k
47 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 678,360 $5.6m0.26% 0.26% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 678.4k
48 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 108,450 $5.5m0.26% 0.26% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 108.5k
49 CENTURY THERAPEUTICS INC COM IPSC IPSC 1,022,892 $3.2m0.15% 0.15% UnchangedShares held: Q3 2022 924.6k, Q4 2022 695.8k, Q1 2023 1.0m, Q2 2023 1.0m
50 HERON THERAPEUTICS INC COM HRTX HRTX 2,086,704 $2.4m0.11% 0.11% ReducedShares held: Q3 2022 8.5m, Q4 2022 6.5m, Q1 2023 3.2m, Q2 2023 2.1m -1.1m -1,148,018 -35.5%
51 ALLAKOS INC COM ALLKG ALLKG 228,277 $995.3k0.05% 0.05% ReducedShares held: Q3 2022 4.5m, Q4 2022 4.9m, Q1 2023 3.6m, Q2 2023 228.3k -3.4m -3,356,723 -93.6%
52 IMMUNIC INC COM COM 308,314 $773.9k0.04% 0.04% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.5m, Q2 2023 308.3k -2.2m -2,215,928 -87.8%
53 MINK THERAPEUTICS INC COM COM 324,867 $682.2k0.03% 0.03% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 324.9k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
IVERIC BIO INC OPHT OPHT 6,500,000 $158.1m6.5m shares
CHINOOK THERAPEUTICS INC ADRO ADRO 3,000,000 $69.5m3.0m shares
REATA PHARMACEUTICALS INC RETA RETA 729,000 $66.3m729.0k shares
BIOGEN INC BIIB BIIB 200,000 $55.6m200.0k shares
DICE THERAPEUTICS INC 1,600,000 $45.8m1.6m shares
EXELIXIS INC EXEL EXEL 1,931,874 $37.5m1.9m shares
DECIPHERA PHARMACEUTICALS IN DCPH DCPH 1,363,201 $21.1m1.4m shares
UNIQURE NV QURE QURE 865,767 $17.4m865.8k shares
ACLARIS THERAPEUTICS INC ACRS ACRS 1,708,971 $13.8m1.7m shares
JOUNCE THERAPEUTICS INC JNCE JNCE 4,259,653 $7.9m4.3m shares
ORCHARD THERAPEUTICS PLC 1,166,670 $6.3m1.2m shares
NKARTA INC NKTX NKTX 1,354,200 $4.8m1.4m shares
2SEVENTY BIO INC TSVT TSVT 350,000 $3.6m350.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
PROTHENA CORP PLC PRTA · Put PRTAPut 250,000 $17.1m250.0k shares New
FIBROGEN INC Call Call 764,700 $2.1m764.7k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 27.

CompanyTickerStakeChange ScheduleLast filed
LB PHARMACEUTICALS INC LBRX · 13D · filed 2026-02-10 LBRX 11.7%≈ $108.8m -3.2 pts 13D 2026-02-10
ALTIMMUNE INC ALT · 13G · filed 2026-04-30 ALT 10.0%≈ $59.0m new 13G 2026-04-30
PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-06 PMN 10.0%≈ $11.9m new 13G 2026-02-06
VERASTEM INC VSTM · 13G · filed 2025-11-21 VSTM 10.0%≈ $29.5m new 13G 2025-11-21
COMPASS PATHWAYS PLC CMPS · 13G · filed 2025-01-17 CMPS 10.0% new 13G 2025-01-17
RAPT THERAPEUTICS INC 13G · filed 2024-12-23 9.9% new 13G 2024-12-23
MOONLAKE IMMUNOTHERAPEUTICS MLTX · 13G · filed 2026-08-14 MLTX 9.7%≈ $155.7m +3.3 pts 13G 2026-08-14
OCULAR THERAPEUTIX INC OCUL · 13G · filed 2026-05-15 OCUL 9.5%≈ $204.7m +4.4 pts 13G 2026-05-15
MAZE THERAPEUTICS INC MAZE · 13G · filed 2025-08-14 MAZE 9.0%≈ $117.8m +2.1 pts 13G 2025-08-14
IMMUNIC INC 13G · filed 2026-03-04 8.7% new 13G 2026-03-04
ALECTOR INC ALEC · 13G · filed 2026-10-23 ALEC 8.6%≈ $21.3m new 13G 2026-10-23
TARSUS PHARMACEUTICALS INC TARS · 13G · filed 2026-05-15 TARS 8.5%≈ $226.6m +1.4 pts 13G 2026-05-15
X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 XFOR 8.3%≈ $37.6m -1.7 pts 13G 2026-08-14
CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2025-05-15 CNTX 8.3%≈ $4.1m 13G 2025-05-15
HEMAB THERAPEUTICS HLDGS INC COAG · 13G · filed 2026-05-08 COAG 8.2%≈ $132.3m new 13G 2026-05-08
CORMEDIX INC CRMD · 13G · filed 2026-05-15 CRMD 7.9%≈ $49.3m +1.7 pts 13G 2026-05-15
NURIX THERAPEUTICS INC NRIX · 13G · filed 2026-08-14 NRIX 7.5%≈ $187.7m +1.3 pts 13G 2026-08-14
CENTURY THERAPEUTICS INC IPSC · 13G · filed 2026-01-15 IPSC 7.3%≈ $33.0m new 13G 2026-01-15
ACLARIS THERAPEUTICS INC ACRS · 13G · filed 2026-03-17 ACRS 7.0%≈ $49.4m new 13G 2026-03-17
AVALO THERAPEUTICS INC AVTX · 13G · filed 2026-08-14 AVTX 6.9%≈ $66.7m +1.1 pts 13G 2026-08-14
MIND MEDICINE MINDMED INC 13G · filed 2025-11-14 6.9% -1.3 pts 13G 2025-11-14
ENGENE HOLDINGS INC 13G · filed 2025-11-18 6.7% +2.3 pts 13G 2025-11-18
BICARA THERAPEUTICS INC BCAX · 13G · filed 2026-05-15 BCAX 6.2%≈ $120.6m +1.2 pts 13G 2026-05-15
ALUMIS INC ALMS · 13G · filed 2026-04-07 ALMS 6.0%≈ $207.2m new 13G 2026-04-07
STRUCTURE THERAPEUTICS INC GPCR · 13G · filed 2026-02-13 GPCR 6.0% -1.4 pts 13G 2026-02-13